These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11767928)

  • 21. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
    Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
    Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
    Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
    Kent MS; Robins TG; Madl AK
    Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying an apppropriate occupational exposure limit (OEL) for beryllium: data gaps and current research initiatives.
    Paustenbach DJ; Madl AK; Greene JF
    Appl Occup Environ Hyg; 2001 May; 16(5):527-38. PubMed ID: 11370933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for chronic beryllium disease using beryllium specific lymphocyte proliferation testing.
    Markham TN
    Int Arch Occup Environ Health; 1996; 68(6):405-7. PubMed ID: 8891776
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and hygienic aspects of consequences of accidents in beryllium plants].
    Krupkin AB; Keĭzer SA; Kovygin GF; Bitkolov NZ; Kagarlitskiĭ AN; Zharkov VIu; Toropov SA; Erasov AI; Khlebalin VI
    Gig Sanit; 1993 Apr; (4):25-7. PubMed ID: 8088574
    [No Abstract]   [Full Text] [Related]  

  • 27. Mortality Among Individuals Diagnosed With Chronic Beryllium Disease and Beryllium Sensitization.
    TenHarmsel H; Wang L; Dumas C; Rosenman KD
    J Occup Environ Med; 2024 Mar; 66(3):247-251. PubMed ID: 38151991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beryllium: a modern industrial hazard.
    Kreiss K; Day GA; Schuler CR
    Annu Rev Public Health; 2007; 28():259-77. PubMed ID: 17094767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3.
    Kreiss K; Mroz MM; Newman LS; Martyny J; Zhen B
    Am J Ind Med; 1996 Jul; 30(1):16-25. PubMed ID: 8837677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Beryllium--underestimated occupational health hazard in Poland].
    Dudek W; Walusiak J; Wittczak T
    Med Pr; 2001; 52(6):471-8. PubMed ID: 11928678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. To Be2+ or not to Be2+: immunogenetics and occupational exposure.
    Newman LS
    Science; 1993 Oct; 262(5131):197-8. PubMed ID: 8105535
    [No Abstract]   [Full Text] [Related]  

  • 33. Beryllium.
    Deubner DC
    J Occup Environ Hyg; 2005 Oct; 2(10):D74-6; author reply D76-8. PubMed ID: 16174633
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of an eight-hour occupational exposure limit for beryllium.
    Wambach PF; Tuggle RM
    Appl Occup Environ Hyg; 2000 Jul; 15(7):581-7. PubMed ID: 10893794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keeping beryllium workers safe: an enhanced preventive model.
    Deubner D; Kent M
    J Occup Environ Hyg; 2007 Mar; 4(3):D23-30. PubMed ID: 17237019
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of beryllium lymphocyte transformation tests in chronic beryllium disease.
    Williams WR; Williams WJ
    Int Arch Allergy Appl Immunol; 1982; 67(2):175-80. PubMed ID: 7056594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Safety criteria in working with metallic beryllium].
    Petrin SV; Petrina LS; Pinaev VS
    Gig Sanit; 2004; (2):28-31. PubMed ID: 15141624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: Lung cancer case-control study of beryllium workers. Sanderson WT, Ward EM, Steenland K, Petersen MR. Am. J. Ind. Med. 2001. 39:133-144.
    Deubner DC; Lockey JL; Kotin P; Powers MB; Miller F; Rogers AE; Trichopoulos D
    Am J Ind Med; 2001 Sep; 40(3):284-8. PubMed ID: 11598976
    [No Abstract]   [Full Text] [Related]  

  • 39. Epidemiological aspects of beryllium-induced nonmalignant lung disease: a 30-year update.
    Eisenbud M; Lisson J
    J Occup Med; 1983 Mar; 25(3):196-202. PubMed ID: 6842310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
    Fontenot AP; Maier LA
    Trends Immunol; 2005 Oct; 26(10):543-9. PubMed ID: 16099719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.